The use of hemospray in portal hypertensive bleeding; a case series

详细信息    查看全文

• 作者：L.A. Smith ; A.J. Morris ; A.J. Stanley
• 关键词：Portal hypertension ; Gastrointestinal bleeding ; Endoscopic hemostasis
• 刊名：Journal of Hepatology
• 出版年：February, 2014
• 年：2014
• 卷：60
• 期：2
• 页码：457-460
• 全文大小：1086 K

文摘

Hemospray is a haemostatic agent licensed for endoscopic haemostasis of non-variceal upper gastrointestinal bleeding (NVUGIB) in Europe and Canada. Hemospray has been shown to be safe and effective in achieving haemostasis in bleeding peptic ulcers in a prospective clinical study and several further case series have described the use of hemospray in other non-variceal causes of gastrointestinal bleeding. Portal hypertensive gastropathy and colopathy are common in patients with portal hypertension. As hemospray is an easy to apply, non-contact method, which can cover large areas of mucosa, it may be of benefit in acute non-variceal portal hypertensive bleeding. We present data from the first four consecutive patients presenting to our institution with acute haemorrhage secondary to non-variceal diffuse portal hypertensive bleeding treated with hemospray.